Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

What's new

Minichiello group discovers a novel stem cell population in the subventricular zone

A new study by the Minichiello group, published in Cell Discovery, has identified a previously unappreciated population of deeply quiescent neural stem cells in the largest germinal zone in the adult mammalian brain, lining the walls of the lateral ventricles, so-called the ventricular-subventricular zone (V-SVZ).

New study reveals specialised subpopulations of head direction cells in the mouse thalamus

Researchers from the Viney Group in the Department of Pharmacology, along with collaborators from The Center for Systems Neuroscience, Boston University, US, have identified distinct subpopulations of head direction (HD) cells in the mouse thalamus, revealing that the brain's internal compass is composed of specialised neurons that differ in their sensorimotor responses, molecular identity, and connectivity.

Lanyon-Hogg group publishes new approach to antibiotic resistance

A new paper, published in Cell Chemical Biology, highlights a new protein in methicillin-resistant Staphylococcus aureus (MRSA) that could be a potential new target for antibiotic drug discovery. The research, carried out in the Lanyon-Hogg group in Pharmacology, in collaboration with the Ineos Oxford Institute for antimicrobial research, shows that molecules targeting this protein, called SpsB, can slow the rate at which MRSA develops resistance to antibiotics such as ciprofloxacin.

Oxford-led study reveals new way to activate protein kinases, opening new therapeutic possibilities

Researchers at the University of Oxford have developed a new strategy to activate protein kinases — a major class of enzymes that regulate essential cellular processes — offering a potential pathway to treat diseases where current therapies remain limited.

We are sorry, but we are unable to retrieve the events at the moment due to a connection issue. Please try to refresh the page or check back later.